NASA Taps Blue Origin for First of Three Uncrewed Lunar Missions as 20 Billion Moon Base Plans Take Shape US Consumer Sentiment Remains Pessimistic Amid Inflation Geopolitical Risks and Trade Policies Social Security Timing Dilemma Claim Now or Wait for Survivor Benefits at 67 RubioModi Talks Focus on US Energy Sales to Offset Iran Conflict Disruptions Kevin Warsh Faces Divided Fed as Inflation Pressures Complicate Rate Cut Debate US Government Stake in Quantum Firms Traders Eye IonQ Micron Anduril as Next Candidates LCTX Q1 2026 Earnings EPS Miss Weighs on Sentiment as ClinicalStage Biotech Continues Pipeline Progress RCON Q4 2025 Earnings NarrowerThanExpected Loss Drives Optimism Despite Revenue Void CBIO Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Progresses MUFG Q1 2026 Earnings Strong EPS Beat Amid Cautious Market Sentiment RenaissanceRe Holdings Ltd RNR Q1 2026 Earnings Strong EPS Beat Drives Investor Attention Despite Stock Decline 51Talk COE Q3 2025 Earnings Reported Loss of 074 Per Share as Stock Declines 37 Rein Therapeutics RNTX Slips Near Support Key Levels Tested Murano Global Investments MRNO Bounces from 030 Support Key Levels to Watch Anfield Energy AEC Surges 9 as Volume Picks Up Eyes Resistance at 499 PLAYSTUDIOS MYPS Bounces Off Support A Closer Look at the Recent Rally Myriad Genetics MYGN Slips as Stock Navigates Support Levels Near 359 Byjus Founder Sentenced to Jail by Singapore Court for Contempt Edtech Turbulence Deepens Foresight Ventures Leads 30 Million Investment in PopDEX to Drive TraderCentric Perpetual DEX Development South Koreas KOSPI Reaches Record High as Asian Markets Eye USIran Talks NBCC Q4 Net Profit Rises 39 to 2535 Crore Board Declares 046 Dividend US April Payrolls Surge Past Expectations But Underlying Economic Concerns Emerge World Bank Data Suggests Automation Could Threaten 69 of Jobs in India South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Disputes NTLA Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Stage Company Focuses on Pipeline Execution Gain Therapeutics GANX Bounces Back Testing Key Resistance at 187